
Prime Minister's Office (Internal), Islamabad — Tender for Bulk Purchase of Medicines (FY 2026-27)
Prime Minister's Office (Internal), Islamabad · Islamabad · The News International,
Tender advertisement published in The News International on Sunday, 13 September 2026, listed under Islamabad, Pakistan. Issued by Prime Minister's Office (Internal), Islamabad. The last date printed on the advertisement was Wednesday, 30 September 2026 and has passed.
The original image is temporarily unavailable. Use the source link or the details below. Open the full-size clipping Advertisement details
Prime Minister's Office (Internal), Islamabad invites bids for the bulk purchase of medicines for FY-2026-27. Registered and reputable firms from Islamabad/Rawalpindi with valid E-PADS 2.0 registration and active GST/NTN may participate.
| Issuer | Prime Minister's Office (Internal), Islamabad |
|---|---|
| Purpose | Bulk purchase of medicines for FY-2026-27 |
| Eligible bidders | Reputed firms of Islamabad / Rawalpindi registered with E-PADS 2.0 and holding valid/active GST & NTN |
| Document availability | E-bidding documents available for registered bidders on E-PADS and at www.epms.ppra.org.pk |
| How to submit | Submit bids on E-PADS and hand in tender documents at R&I Section, Prime Minister's Office (Internal), Islamabad |
| Submission deadline | 2026-09-30 (before 11:00 AM) |
| Tender opening | 2026-09-30 at 11:30 AM |
| Taxes | All applicable Government taxes must be included in the tenders |
| Authority note | As per Section 33 of the PPRA Rules, the tender-issuing authority reserves the right to accept or reject any tender |
| Contact | Phone: 051-9045262 (during office hours) |
| Reference | PID (I) No. 2415/26 |
Bidders should follow the detailed terms and conditions in the e-bidding documents available on E-PADS and www.epms.ppra.org.pk.
Published in The News International on Sunday, 13 September 2026. DailyAds.pk indexes newspaper advertisements; the original notice and the issuing organisation remain the source for final terms and eligibility.










